🇺🇸 KRYS — Krystal Biotech, Inc.

Salud Compra fuerte
← Volver

Precio actual

300,25 USD

Máx. histórico

378,15

129 días

Caída desde máximo

-20,60%

Rango 52 semanas

192,52 – 382,54

Variación hoy

-3,41%

Cierre anterior

310,84

Rango de hoy

299,64 – 314,24

Volumen hoy

400.881

Peor caída histórica

-53,42%

01/03/2021 → 26/11/2021

Recuperado en 3 días

Volatilidad anualizada ⓘ

73,05%

Información
Nombre completo
Krystal Biotech, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
295
PER ⓘ
40,79 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
388,22 USD (puede no estar actualizado)
Primera cotización
20/09/2017
Precio actualizado
hace 21 horas
Sobre la empresa

Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/03/2020 53,82 58,49 52,84 58,35 +9,17% 10,50% 130.100
28/02/2020 50,35 53,45 48,89 53,45 +1,81% 9,06% 140.500
27/02/2020 53,85 53,96 50,02 52,50 -4,55% 7,31% 202.000
26/02/2020 53,55 56,11 53,33 55,00 +3,00% 5,19% 65.000
25/02/2020 57,55 58,04 52,32 53,40 -7,98% 9,94% 147.300
24/02/2020 56,91 58,78 55,54 58,03 -2,11% 5,69% 80.200
21/02/2020 60,44 61,50 58,50 59,28 -2,26% 4,96% 84.300
20/02/2020 62,45 63,51 59,46 60,65 -3,27% 6,49% 84.500
19/02/2020 62,34 63,55 62,01 62,70 +0,79% 2,47% 103.000
18/02/2020 64,04 64,31 61,86 62,21 -3,33% 3,83% 73.300
14/02/2020 64,64 65,48 62,58 64,35 -0,25% 4,49% 144.300
13/02/2020 65,23 66,85 64,45 64,51 -1,72% 3,68% 106.400
12/02/2020 64,22 65,85 62,97 65,64 +3,48% 4,48% 101.400
11/02/2020 60,03 64,20 60,03 63,43 +6,59% 6,95% 190.400
10/02/2020 58,42 60,09 58,30 59,51 +1,57% 3,06% 152.700
07/02/2020 58,16 59,53 57,31 58,59 -0,53% 3,82% 43.300
06/02/2020 59,11 59,47 57,59 58,90 -0,03% 3,19% 108.600
05/02/2020 59,24 61,80 56,54 58,92 +0,72% 8,88% 81.000
04/02/2020 55,43 58,80 55,43 58,50 +7,06% 6,08% 116.100
03/02/2020 52,57 54,84 52,05 54,64 +4,55% 5,31% 107.200
31/01/2020 52,48 53,98 51,52 52,26 -1,04% 4,69% 106.400
30/01/2020 54,89 57,45 52,42 52,81 -4,95% 9,17% 101.000
29/01/2020 58,72 59,45 55,05 55,56 -4,45% 7,51% 122.000
28/01/2020 58,17 59,44 57,14 58,15 +0,68% 3,95% 119.000
27/01/2020 54,68 58,95 54,14 57,76 +3,11% 8,80% 109.900
24/01/2020 56,27 56,83 54,75 56,02 -0,02% 3,69% 134.100
23/01/2020 56,55 57,35 55,00 56,03 -1,43% 4,15% 562.700
22/01/2020 54,68 58,08 54,17 56,84 +4,47% 7,16% 335.300
21/01/2020 51,74 55,23 50,55 54,41 +4,98% 9,05% 146.700
17/01/2020 52,60 53,43 50,77 51,83 -0,82% 5,06% 162.800